Patients with glioblastoma, a devastating brain cancer, receive treatment that frequently leads to the unfortunate side effect of low white blood cell counts that lasts six months to a year. The low numbers of white blood cells are associated with shorter survival — but the specific reason for the prolonged drop in white blood cells […]
Patients with brain cancer may benefit from treatment to boost white blood cells
![](https://neuroscienceresearch.wustl.edu/files/2023/01/1-27-2023_Patients-with-brain-cancer-may-benefit-from-treatment-to-boost-white-blood-cells-350x233.jpg)